Interactions of metallopharmaceuticals with DNA.
Clarke
M J
MJ
Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02167, USA.
Stubbs
M
M
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use; D001665:Binding Sites; D004247:DNA / Q000737:chemistry*; D004249:DNA Damage; D008670:Metals / Q000737:chemistry* / Q000627:therapeutic use; D015394:Molecular Structure; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009690:Nucleic Acid Conformation; D009942:Organometallic Compounds / Q000737:chemistry* / Q000627:therapeutic use; D011687:Purines; D012238:Rhodium / Q000737:chemistry; D012428:Ruthenium / Q000737:chemistry; D014025:Titanium / Q000737:chemistry
D000970:Antineoplastic Agents; D008670:Metals; D009942:Organometallic Compounds; D011687:Purines; D012428:Ruthenium; D004247:DNA; D014025:Titanium; D012238:Rhodium